Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Conmed (CNMD) Net Margin (2016 - 2025)

Conmed's Net Margin history spans 16 years, with the latest figure at 4.49% for Q4 2025.

  • For Q4 2025, Net Margin fell 527.0% year-over-year to 4.49%; the TTM value through Dec 2025 reached 3.42%, down 671.0%, while the annual FY2025 figure was 3.42%, 671.0% down from the prior year.
  • Net Margin reached 4.49% in Q4 2025 per CNMD's latest filing, up from 0.85% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 16.78% in Q3 2022 to a low of 60.71% in Q2 2022.
  • Average Net Margin over 5 years is 3.57%, with a median of 6.09% recorded in 2022.
  • Peak YoY movement for Net Margin: plummeted -6592bps in 2022, then surged 6504bps in 2023.
  • A 5-year view of Net Margin shows it stood at 8.92% in 2021, then rose by 19bps to 10.6% in 2022, then fell by -5bps to 10.11% in 2023, then fell by -4bps to 9.76% in 2024, then plummeted by -54bps to 4.49% in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Net Margin are 4.49% (Q4 2025), 0.85% (Q3 2025), and 6.26% (Q2 2025).